[go: up one dir, main page]

AP2003002817A0 - Water-soluble powdery or granular compositions based on phernantridines and their uses - Google Patents

Water-soluble powdery or granular compositions based on phernantridines and their uses

Info

Publication number
AP2003002817A0
AP2003002817A0 AP2003002817A AP2003002817A AP2003002817A0 AP 2003002817 A0 AP2003002817 A0 AP 2003002817A0 AP 2003002817 A AP2003002817 A AP 2003002817A AP 2003002817 A AP2003002817 A AP 2003002817A AP 2003002817 A0 AP2003002817 A0 AP 2003002817A0
Authority
AP
ARIPO
Prior art keywords
phernantridines
water
compositions based
granular compositions
soluble powdery
Prior art date
Application number
AP2003002817A
Other versions
AP1704A (en
Original Assignee
Vibrac S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vibrac S A filed Critical Vibrac S A
Publication of AP2003002817A0 publication Critical patent/AP2003002817A0/en
Application granted granted Critical
Publication of AP1704A publication Critical patent/AP1704A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/2003/002817A 2001-01-08 2002-01-03 Water-soluble powdery or granular compositions based on phenanthridines and their uses. AP1704A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0100170A FR2819188B1 (en) 2001-01-08 2001-01-08 WATER-SOLUBLE PULVERULENT OR GRANULATED COMPOSITIONS BASED ON PHENANTHRIDINES AND USES THEREOF
PCT/FR2002/000008 WO2002053132A1 (en) 2001-01-08 2002-01-03 Water-soluble powdery or granular compositions based on phenanthridines and their uses

Publications (2)

Publication Number Publication Date
AP2003002817A0 true AP2003002817A0 (en) 2003-06-30
AP1704A AP1704A (en) 2007-01-02

Family

ID=8858580

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2003/002817A AP1704A (en) 2001-01-08 2002-01-03 Water-soluble powdery or granular compositions based on phenanthridines and their uses.

Country Status (4)

Country Link
AP (1) AP1704A (en)
FR (1) FR2819188B1 (en)
OA (1) OA12437A (en)
WO (1) WO2002053132A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2416004B1 (en) * 2012-01-24 2014-01-28 Investigaciones Farmaceuticas Y Veterinarias, S.L. PHARMACEUTICAL COMPOSITION THAT INCLUDES ISOMETAMIDIUM CHLORIDE IN SOLUTION FOR THE TREATMENT OF TRIPANOSOMIASIS IN ANIMALS.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB904797A (en) * 1959-12-23 1962-08-29 Boots Pure Drug Co Ltd Ophthalmic medicaments comprising phenanthridinium salts
ZW3385A1 (en) * 1985-03-01 1986-09-24 David John Fluck Liposomes,process for their preparation and compositions containing them

Also Published As

Publication number Publication date
WO2002053132A1 (en) 2002-07-11
OA12437A (en) 2006-05-22
FR2819188A1 (en) 2002-07-12
FR2819188B1 (en) 2003-03-14
AP1704A (en) 2007-01-02

Similar Documents

Publication Publication Date Title
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
AU2002357119A8 (en) Mitocidal compositions and methods
AU2003227480A1 (en) Modified polymers and compositions containing the same
AU2002367717A8 (en) Nano-particle preparation and applications
HUP0303825A3 (en) 1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
AU2001294814A1 (en) Pumpcn compositions and uses thereof
MXPA03006788A (en) Water soluble powders and tablets.
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
IL158671A0 (en) Benzyloxy derivatives and pharmaceutical compositions containing the same
MXPA03007416A (en) Water-borne paint composition having improved hiding and scrub-resistance.
IL209475A0 (en) Colloidal gold compositions and their uses
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
EP1450610A4 (en) Probiotic compositions
IL160984A0 (en) Triazine derivatives and pharmaceutical compositions containing the same
AU2002357748A8 (en) Osteopontin-related compositions and methods
GB0126889D0 (en) Compounds and their uses
GB0104233D0 (en) Powder composition
AP2003002817A0 (en) Water-soluble powdery or granular compositions based on phernantridines and their uses
AU2002228135A1 (en) Water-soluble powdery or granular compositions based on phenanthridines and their uses
IL162223A0 (en) 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof
GB0013503D0 (en) Pharmaceutical compositions and their uses
GB0207224D0 (en) Tenascin-W compositions and uses thereof
AU2002359869A8 (en) Pak5-related compositions and methods